US 11,998,609 B2
Self-assembling antiviral prodrugs
Honggang Cui, Baltimore, MD (US); Charles Williams Flexner, Baltimore, MD (US); Maya Monroe, Baltimore, MD (US); and Han Wang, Baltimore, MD (US)
Assigned to The Johns Hopkins University, Baltimore, MD (US)
Filed by The Johns Hopkins University, Baltimore, MD (US)
Filed on Nov. 7, 2022, as Appl. No. 17/981,595.
Claims priority of provisional application 63/277,144, filed on Nov. 8, 2021.
Prior Publication US 2023/0147365 A1, May 11, 2023
Int. Cl. A61K 47/64 (2017.01); A61P 31/18 (2006.01); A61P 31/20 (2006.01)
CPC A61K 47/64 (2017.08) [A61P 31/18 (2018.01); A61P 31/20 (2018.01)] 8 Claims
 
1. A composition comprising a peptide-based antiretroviral therapeutic (ARV) prodrug selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry